Special Issue "Haematological Neoplasms: Diagnosis and Management"
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 28964
Interests: hematopathology; immunohistochemistry; lymphoid neoplasms; myeloid neoplasms
Interests: surgical pathology; lymphoproliferative diseases; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue in Diagnostics: Biomarkers and Therapeutic Advances in Bladder Cancer
Special Issue in International Journal of Molecular Sciences: Urogenital Tumors: From Molecular Basis to Therapy
The latest WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition, dates back to 2017, and there is a huge ongoing work for the new edition to be published within the coming years as part of the novel 5th Edition series. This work is focused on the analysis, discussion, and potential endorsement of the recent advances in the pathology and molecular biology of haematological neoplasms.
We are pleased to invite you to submit your research works to this Special Issue, which aims to shape the current landscape of the diagnosis and management of haematological neoplasms of both myeloid and lymphoid origin by critically assessing the more recent technological advances in the recognition of novel pathological entities, the detection of prognostic and predictive biomarkers, and the application of precision medicine tools.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) ancillary techniques (including immunohistochemistry, PCR-based methods, and cytogenetics), the identification of prognostic/predictive biomarkers, issues in the diagnosis/differential diagnosis of challenging entities, and the current role of pathology in tailored therapy and precision medicine.
We look forward to receiving your contributions.
Prof. Dr. Stefano Ascani
Prof. Dr. Francesca Sanguedolce
Dr. Magda Zanelli
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- myeloid neoplasms
- lymphoid neoplasms
- molecular biology
- precision medicine